Community-Based Diabetes Prevention Program in Thai populatio
Not Applicable
Completed
- Conditions
- Impaired glucose toleranceprediabetesimpaired glucose tolerancediabetes prevention program
- Registration Number
- TCTR20180807001
- Lead Sponsor
- ational Health Security Office
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1926
Inclusion Criteria
1.Residing in the jurisdiction of the selected PCUs and planning to stay in the area for at least 3 years.
2.Aged 30â€65 years.
3.No prior diagnosis of diabetes.
4.Impaired glucose tolerance, defined as a 2-h postload glucose of 140â€199 mg/dL.
Exclusion Criteria
Individuals with ischemic heart disease, aortic stenosis, uncontrolled hypertension, and renal diseases. We also excluded pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diabetes Incidence 2 years Plasma Glucose
- Secondary Outcome Measures
Name Time Method BMI 2 years weight/Height squared
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are targeted by community-based interventions in impaired glucose tolerance populations?
How does the TCTR20180807001 program compare to metformin in preventing type 2 diabetes in Thai prediabetic patients?
Which biomarkers correlate with successful glycemic control in lifestyle-focused diabetes prevention trials?
What adverse events are associated with intensive lifestyle modifications in community-based diabetes prevention programs?
Are there combination therapies with GLP-1 agonists or SGLT2 inhibitors that enhance outcomes in impaired glucose tolerance prevention studies?